Sunday 11 October 2026 Export all VXRT data to Excel Powerpack

VAXART, INC.

VXRT Healthcare Biotechnology

VAXART, INC.’s revenue for fiscal 2025 (year ended December 2025) was $237.3 million, up 726.7% from fiscal 2024. In the quarter to June 2026, revenue fell 31.6%, EPS grew 14.3% and free cash flow grew 117.4%, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

0.43 0.00 0.00%
Market cap
$92.4M
P/E
2.8×
Fwd P/E
2.1×
Dividend yield
—
F-score
6/9
Altman Z
−1.06
Beneish M
3.73
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
3.81 4.07 5.83 0.00

+8 more quarters

P/S ratio
0.61 0.57 0.34 0.56
P/FCF ratio
4.42 9.92 10.64 0.00
P/Operating CF
53.18 (71.47) 2.63 31.76
P/B ratio
1.79 1.56 0.92 3.08
Price to Tangible BV
1.96 1.69 1.00 4.28
EV/Sales
0.35 0.34 0.08 0.37
EV/EBITDA
1.87 1.91 0.68 0.00
EV/Operating CF
2.50 5.70 2.33 (1.81)
EV/FCF
2.54 5.87 2.37 (1.80)
Quick Ratio
1.52 1.54 1.33 0.68
Current Ratio
1.60 1.71 1.57 0.69
Net Debt/EBITDA
5.11 (9.77) (1.12) 5.17
Debt/Assets
0.00% 0.00% 0.00% 0.00%
Debt/Equity
0.00 0.00 0.00 0.00
Asset Turnover
1.48 1.51 1.35 0.79
Operating CF/Net income
(0.21) (0.40) 0.56 (0.32)
Capex/Depreciation
(0.04) (0.42) 0.00 (0.05)
Interest Coverage
(24.48) 10.24 101.51 (12.85)
Research and Development Expense of Revenue
124.16% 74.98% 43.31% 104.88%
Selling, General and Administrative Expense of Revenue
24.29% 11.83% 3.52% 5.91%
Intangible Assets out of Total Assets
0.04 0.04 0.04 0.04
Share Based Compensation of Revenue
4.75% 3.78% 1.65% 2.79%
Graham Net Nets
0.23 0.31 0.47 (0.79)
Graham Number
1.11 1.15 0.72 0.00
Earnings Yield
26.23% 24.59% 17.14% (63.89%)
Free Cash Flow Yield
22.61% 10.08% 9.40% (36.98%)
Revenue per Share
0.11 0.16 0.45 0.32
Operating CF per Share
0.01 (0.01) 0.13 0.01
Capex per Share
0.00 0.00 0.00 0.00
Free Cash Flow per Share
0.01 (0.01) 0.13 0.01
Cash per Share
0.26 0.25 0.28 0.13
Shareholders Equity per Share
0.34 0.39 0.38 0.12
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
0.34 0.39 0.38 0.12
Free Cash Flow
2.75 (2.50) 30.66 2.48
Working Capital
43.58 54.86 49.37 (51.93)
Capital Expenditures
(0.02) (0.44) 0.00 (0.11)
Net Current Asset Value
33.88 45.77 37.84 (64.86)
EV/EBIT
2.14 2.28 0.99 0.00
Capex to Sales
0.00 0.01 0.00 0.00
Price to Operating Income
3.73 3.84 4.46 0.00
Other line items
Average Receivables
44.03 36.85 31.66 44.81
Average Payables
13.79 20.40 14.23 27.80
Average Assets
164.64 169.31 176.23 187.83
Average Common Equity
57.62 69.87 73.36 47.60

Fold the line items

Columns are period end dates